Clinical Trials

Title   [1005180-2] A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Efficacy and Safety of DigiFab® in Antepartum Subjects with Severe Preeclampsia
Description   This study evaluates the use of Digoxin immune fab in addition to expectant management in the treatment of severe preeclampsia as compared to placebo.
IRB Number   17-019
Treatment   Preeclampsia
Status   Active
Principal Name   Brian Brocato, D.O.
Contact Name   Casey Armistead

Email Newsletters

Connect With Us